The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
April 19th 2024
HIV testing uptake was improved in immigrants after peer interventions with multiple strategies were implemented.
Deaths From Hepatitis C Virus Hit All-Time High, CDC Reports
May 4th 2016CDC also published a separate study that found more people in the United States now die from hepatitis C than die from HIV or any other infectious disease. The report comes as The American Journal of Managed Care publishes a special issue on policy concerns over patient access to new therapies that cure HCV.
Read More
Improving HCV Cure Rates in HIV-Coinfected Patients - A Real-World Perspective
The authors examine real-world hepatitis C virus cure rates with direct-acting antivirals among patients coinfected with HIV.
Read More
Single- Versus Multiple-Tablet HIV Regimens: Adherence and Hospitalization Risk
Single-tablet regimens are associated with higher adherence rates, decreased hospitalizations, and a higher proportion of patients with undetectable viral load compared with multiple-tablet regimens in patients with HIV/AIDS.
Read More
What We're Reading: Sanders Proposes HIV/AIDS Drug Development Prize Fund
March 15th 2016What we're reading, March 15, 2016: Bernie Sanders proposes a prize fund to spur drug development for HIV/AIDS; one news outlet is going to court to unseal documents related to OxyContin's marketing; and report highlights the emotional trauma healthcare providers face after making a serious medical error.
Read More
On World AIDS Day, the Evidence for Prevention With Anti-Retroviral Therapy Is Powerful
December 1st 2015Anthony S. Fauci, MD, of the National Institute of Allergy and Infectious Disease, co-authors an article that calls for broader use of ART to bring about the end of AIDS, more than 30 years after the dawn of the pandemic.
Read More
Kaiser Poll Finds Strong Support to Control Drug Prices
April 21st 2015The Kaiser Health Tracking Poll found Americans strongly support ensuring that those with chronic conditions like cancer, HIV, and mental illness can have access to affordable drugs, and this sentiment was shared across partisan lines.
Read More
Delayed HCV Treatment in Coinfected Patients Can Prove Fatal
March 2nd 2015Modeling data discussed at a press conference at the 2015 Conference on Retroviruses and Opportunistic Infections showed that delaying HCV treatment, consequent to the high cost of the newer antiviral regimens, could prove fatal in patients coninfected with HIV.
Read More
Insurers Find New Way to Discriminate Against Patients
January 31st 2015Although one of the central features of the Affordable Care Act was eliminating discrimination based on preexisting conditions, there is evidence insurers have found ways to dissuade high-cost patients from enrolling in their plans.
Read More
Aetna Faces Class Action Lawsuit Over Mail-Order Requirement for HIV Drugs
December 29th 2014The plaintiff, John Doe, alleges that not having access to a community pharmacist will limit his ability to gain counseling on potential drug interactions. United Healthcare settled a similar action earlier in 2014. Consumer groups have also alleged discrimination against HIV patients by insurers over drug access in Florida.
Read More
On World AIDS Day, Advocates Mark "Tipping Point" Amid Complaints About Drug Prices in US
December 1st 2014On World AIDS Day, advocates mark "the beginning of the end" of the pandemic. In the United States, 2014 has been marked by battles between patient advocacy groups and some payers over the price of generic HIV drugs on exchanges under the Affordable Care Act.
Read More
CDC Lab Safety Point Person, Dr. Michael Bell, to Give Keynote on Hospital Safety at AJMCLive Event
July 24th 2014Dr. Michael Bell, previously announced as the keynote speaker for the September 25-26 live meeting hosted by The American Journal of Managed Care, this weekend discussed his role in overhauling lab safety at the Centers for Disease Control and Prevention in Atlanta. Attendees at AJMCLive's Atlanta conference, "Value-Based Decision-Making in Infectious Disease," will have the chance to hear Dr. Bell discuss the prevention of hospital-acquired infections.
Read More
Patient Advocates Voice Concern Over Drug Benefit Plan Design
July 8th 2014The Affordable Care Act (ACA) prohibits insurance companies from rejecting new customers based on their pre-existing health conditions. Yet, a recent report alleged that 4 Florida-based payers may have structured their prescription drug benefit plans in a way which does just that.
Read More
CDC's Michael Bell to Give Keynote at AJMC Infectious Disease Conference in Atlanta
June 30th 2014The American Journal of Managed Care will host a two-day event September 25-26, 2014, in Atlanta taking on some of healthcare's biggest challenges in infectious disease, including HIV, MERS and how to pay for new therapies for hepatitis C. Giving the keynote address will be Michael Bell, MD, deputy director of the Centers for Disease Control and Prevention's Division of Healthcare Quality Promotion.
Read More